Cargando…

Deficiency of terminal complement pathway inhibitor promotes neuronal tau pathology and degeneration in mice

BACKGROUND: The neuronal microtubule-associated protein tau becomes hyperphosphorylated and forms aggregates in tauopathies but the processes leading to this pathological hallmark are not understood. Because tauopathies are accompanied by neuroinflammation and the complement cascade forms a key inna...

Descripción completa

Detalles Bibliográficos
Autores principales:	Britschgi, Markus, Takeda-Uchimura, Yoshiko, Rockenstein, Edward, Johns, Hudson, Masliah, Eliezer, Wyss-Coray, Tony
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Short Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3511294/ https://www.ncbi.nlm.nih.gov/pubmed/22989354 http://dx.doi.org/10.1186/1742-2094-9-220

Ejemplares similares

Regulation of Amyloid Precursor Protein Processing by the Beclin 1 Complex
por: Jaeger, Philipp A., et al.
Publicado: (2010)

APP transgenic modeling of Alzheimer’s disease: mechanisms of neurodegeneration and aberrant neurogenesis
por: Crews, Leslie, et al.
Publicado: (2009)

Neuroprotective effects of Cerebrolysin in triple repeat Tau transgenic model of Pick’s disease and fronto-temporal tauopathies
por: Rockenstein, Edward, et al.
Publicado: (2015)

Brain-derived exosomes from dementia with Lewy bodies propagate α-synuclein pathology
por: Ngolab, Jennifer, et al.
Publicado: (2017)

Correction to: Brain-derived exosomes from dementia with Lewy bodies propagate α-synuclein pathology
por: Ngolab, Jennifer, et al.
Publicado: (2020)

ESCRT-mediated Uptake and Degradation of Brain-targeted α-synuclein Single Chain Antibody Attenuates Neuronal Degeneration In Vivo
por: Spencer, Brian, et al.
Publicado: (2014)

A Novel Triple Repeat Mutant Tau Transgenic Model That Mimics Aspects of Pick’s Disease and Fronto-Temporal Tauopathies
por: Rockenstein, Edward, et al.
Publicado: (2015)

Lenalidomide reduces microglial activation and behavioral deficits in a transgenic model of Parkinson’s disease
por: Valera, Elvira, et al.
Publicado: (2015)

Role of Alterations in Protein Kinase p38γ in the Pathogenesis of the Synaptic Pathology in Dementia With Lewy Bodies and α-Synuclein Transgenic Models
por: Iba, Michiyo, et al.
Publicado: (2020)

Granulovacuolar degeneration bodies: red alert for neurons with MAPT/tau pathology
por: Wiersma, Vera I., et al.
Publicado: (2019)

Human P301L-Mutant Tau Expression in Mouse Entorhinal-Hippocampal Network Causes Tau Aggregation and Presynaptic Pathology but No Cognitive Deficits
por: Harris, Julie A., et al.
Publicado: (2012)

Modelling neuroinflammatory phenotypes in vivo
por: Buckwalter, Marion S, et al.
Publicado: (2004)

Concurrent tau pathologies in frontotemporal lobar degeneration with TDP‐43 pathology
por: Koga, Shunsuke, et al.
Publicado: (2021)

Microglial complement receptor 3 regulates brain Aβ levels through secreted proteolytic activity
por: Czirr, Eva, et al.
Publicado: (2017)

Oligomer-prone E57K-mutant alpha-synuclein exacerbates integration deficit of adult hippocampal newborn neurons in transgenic mice
por: Regensburger, Martin, et al.
Publicado: (2017)

Tau Reduction Does Not Prevent Motor Deficits in Two Mouse Models of Parkinson's Disease
por: Morris, Meaghan, et al.
Publicado: (2011)

A brain-targeted, modified neurosin (kallikrein-6) reduces α-synuclein accumulation in a mouse model of multiple system atrophy
por: Spencer, Brian, et al.
Publicado: (2015)

All-you-can-eat: autophagy in neurodegeneration and neuroprotection
por: Jaeger, Philipp A, et al.
Publicado: (2009)

Granulovacuolar degeneration bodies are neuron-selective lysosomal structures induced by intracellular tau pathology
por: Wiersma, Vera I., et al.
Publicado: (2019)

Phosphorylation of collapsin response mediator protein-2 disrupts neuronal maturation in a model of adult neurogenesis: Implications for neurodegenerative disorders
por: Crews, Leslie, et al.
Publicado: (2011)

Terminal Complement Pathway Deficiency in an Adult Patient with Meningococcal Sepsis
por: Staels, F., et al.
Publicado: (2022)

Anti-α-synuclein immunotherapy reduces α-synuclein propagation in the axon and degeneration in a combined viral vector and transgenic model of synucleinopathy
por: Spencer, Brian, et al.
Publicado: (2017)

Beclin 1 regulates neuronal transforming growth factor-β signaling by mediating recycling of the type I receptor ALK5
por: O’Brien, Caitlin E., et al.
Publicado: (2015)

Peptides of Presenilin-1 Bind the Amyloid Precursor Protein Ectodomain and Offer a Novel and Specific Therapeutic Approach to Reduce ß-Amyloid in Alzheimer’s Disease
por: Dewji, Nazneen N., et al.
Publicado: (2015)

The Temporal Expression Pattern of Alpha-Synuclein Modulates Olfactory Neurogenesis in Transgenic Mice
por: Schreglmann, Sebastian R., et al.
Publicado: (2015)

Active immunization against alpha-synuclein ameliorates the degenerative pathology and prevents demyelination in a model of multiple system atrophy
por: Mandler, Markus, et al.
Publicado: (2015)

Identification of the Sites of Tau Hyperphosphorylation and Activation of Tau Kinases in Synucleinopathies and Alzheimer’s Diseases
por: Duka, Valeriy, et al.
Publicado: (2013)

Prediction of conversion from mild cognitive impairment to dementia with neuronally derived blood exosome protein profile
por: Winston, Charisse N., et al.
Publicado: (2016)

Granulovacuolar degeneration bodies are independently induced by tau and α-synuclein pathology
por: Jorge-Oliva, Marta, et al.
Publicado: (2022)

In Vivo Imaging of α-Synuclein in Mouse Cortex Demonstrates Stable Expression and Differential Subcellular Compartment Mobility
por: Unni, Vivek K., et al.
Publicado: (2010)

The small molecule alpha-synuclein misfolding inhibitor, NPT200-11, produces multiple benefits in an animal model of Parkinson’s disease
por: Price, Diana L., et al.
Publicado: (2018)

Association of Retromer Deficiency and Tau Pathology in Down Syndrome
por: Curtis, Mary Elizabeth, et al.
Publicado: (2022)

Pathological tau deposition in Motor Neurone Disease and frontotemporal lobar degeneration associated with TDP-43 proteinopathy
por: Behrouzi, Roya, et al.
Publicado: (2016)

Regulation of age-related macular degeneration-like pathology by complement factor H
por: Toomey, Christopher B., et al.
Publicado: (2015)

Complement-Mediated Microglial Phagocytosis and Pathological Changes in the Development and Degeneration of the Visual System
por: Borucki, Davis M., et al.
Publicado: (2020)

Complement C3 deficiency alleviates alkylation-induced retinal degeneration in mice
por: Du, Lu, et al.
Publicado: (2022)

Bioluminescence in vivo imaging of autoimmune encephalomyelitis predicts disease
por: Luo, Jian, et al.
Publicado: (2008)

Unraveling protein dynamics to understand the brain – the next molecular frontier
por: Brewer, Kyle D., et al.
Publicado: (2022)

Plasma tau complements CSF tau and P-tau in the diagnosis of Alzheimer's disease
por: Fossati, Silvia, et al.
Publicado: (2019)

Re-examining tau-immunoreactive pathology in the population: granulovacuolar degeneration and neurofibrillary tangles
por: Hunter, Sally, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_lps893lkqujchd67ulmm3pj4po